These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38036798)

  • 1. A Bayesian Approach to Kinetic Modeling of Accelerated Stability Studies and Shelf Life Determination.
    Chau J; Altan S; Burggraeve A; Coppenolle H; Kifle YW; Prokopcova H; Van Daele T; Sterckx H
    AAPS PharmSciTech; 2023 Nov; 24(8):250. PubMed ID: 38036798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using accelerated drug stability results to inform long-term studies in shelf life determination.
    Faya P; Seaman JW; Stamey JD
    Stat Med; 2018 Jul; 37(17):2599-2615. PubMed ID: 29766536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic Model Development for Accelerated Stability Studies.
    Clancy D; Hodnett N; Orr R; Owen M; Peterson J
    AAPS PharmSciTech; 2017 May; 18(4):1158-1176. PubMed ID: 27422651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.
    Waterman KC
    AAPS PharmSciTech; 2011 Sep; 12(3):932-7. PubMed ID: 21748541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.
    Waterman KC; Carella AJ; Gumkowski MJ; Lukulay P; MacDonald BC; Roy MC; Shamblin SL
    Pharm Res; 2007 Apr; 24(4):780-90. PubMed ID: 17372701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of in-use stability for tablets and powders in bottles.
    Waterman KC; Chen L; Waterman P; MacDonald BC; Monahan AP; Scrivens G
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1571-8. PubMed ID: 27050806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical prediction of drug stability based on nonlinear parameter estimation.
    King SY; Kung MS; Fung HL
    J Pharm Sci; 1984 May; 73(5):657-62. PubMed ID: 6737241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bayesian approach to Arrhenius prediction of shelf-life.
    Su XY; Li Wan Po A; Yoshioka S
    Pharm Res; 1994 Oct; 11(10):1462-6. PubMed ID: 7855053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical solid-state kinetic stability investigation by using moisture-modified Arrhenius equation and JMP statistical software.
    Fu M; Perlman M; Lu Q; Varga C
    J Pharm Biomed Anal; 2015 Mar; 107():370-7. PubMed ID: 25656488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Modern Approach to Stability Studies via Bayesian Linear Mixed Models Incorporating Auxiliary Effects.
    Cordero M; Meinfelder F; Eilert T
    J Pharm Sci; 2024 Jul; 113(7):1779-1793. PubMed ID: 38417792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Monitoring of Shelf Lives of Materials by Application of Data Loggers with Implemented Kinetic Parameters.
    Roduit B; Luyet CA; Hartmann M; Folly P; Sarbach A; Dejeaifve A; Dobson R; Schroeter N; Vorlet O; Dabros M; Baltensperger R
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31200557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization Risk Assessment of Amorphous Solid Dispersions by Physical Shelf-Life Modeling: A Practical Approach.
    Liu B; Theil F; Lehmkemper K; Gessner D; Li Y; van Lishaut H
    Mol Pharm; 2021 Jun; 18(6):2428-2437. PubMed ID: 34032433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated shelf life modeling of appearance change in drug products using ASAP
    Flavier K; McLellan J; Botoy T; Waterman KC
    Pharm Dev Technol; 2022 Jul; 27(6):740-748. PubMed ID: 35950863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humidity-corrected Arrhenius equation: The reference condition approach.
    Naveršnik K; Jurečič R
    Int J Pharm; 2016 Mar; 500(1-2):360-5. PubMed ID: 26802498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of drug substance predicted chemical stability with ICH compliant stability studies.
    Williams HE; Bright J; Roddy E; Poulton A; Cosgrove SD; Turner F; Harrison P; Brookes A; MacDougall E; Abbott A; Gordon C
    Drug Dev Ind Pharm; 2019 Mar; 45(3):379-386. PubMed ID: 30395722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic Modeling.
    Evers A; Clénet D; Pfeiffer-Marek S
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhenius time-scaled least squares: a simple, robust approach to accelerated stability data analysis for bioproducts.
    Rauk AP; Guo K; Hu Y; Cahya S; Weiss WF
    J Pharm Sci; 2014 Aug; 103(8):2278-86. PubMed ID: 24974956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.